Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Heart Rate Reduction With Esmolol is Associated With Improved Arterial Elastance in Patients With Septic Shock. A Prospective Observational Study

NCT02188888 is registered in ClinicalTrials.gov with University of Roma La Sapienza as lead sponsor.

NCT NCT02188888
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02188888 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Heart Rate Reduction With Esmolol is Associated With Improved Arterial Elastance in Patients With Septic Shock. A Prospective Observational Study
Lead sponsor
University of Roma La Sapienza
Phase
Observational
Overall status
Completed
Start date
December 31, 2013
Completion date
June 30, 2014
Enrollment
45 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock, tachycardia